The RIP1-kinase inhibitor Necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice

Journal of the American Society of Nephrology

Volumn 24, Issue 10, 2013, Pages 1545-1557

  Linkermann, Andreas ^a   Heller, Jan Ole ^a   Prókai, Ágnes ^b   Weinberg, Joel M ^c   Zen, Federica De ^a   Himmerkus, Nina ^a   Szabó, Attila J ^a   Bräsen, Jan H ^a,d   Kunzendorf, Ulrich ^a   Krautwald, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Institute for Diagnostic Histopathology and Cytopathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; CONTRAST MEDIUM; CREATININE; NECROSTATIN 1; PHOSPHATE BUFFERED SALINE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RECEPTOR INTERACTING PROTEIN 1 KINASE; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CELL MEMBRANE; CELL VIABILITY; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SPECIFICITY; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; INTRAVITAL MICROSCOPY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MICROSCOPY; MOUSE; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REPERFUSION INJURY; UREA BLOOD LEVEL;

EID: 84885066591     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012121169     Document Type: Article

References (60)

1. Calvin AD, Misra S, Pflueger A: Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol 6: 679-688, 2010
2. McCullough PA: Radiocontrast-induced acute kidney injury. Nephron, Physiol 109: 61-72, 2008
3. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Sonel AF, Fine MJ, Palevsky PM: Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med 168: 1325-1332, 2008
4. Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F: Persistent renal damage after contrast-induced acute kidney injury: Incidence, evolution, risk factors, and prognosis. Circulation 125: 3099-3107, 2012
5. Budano C, Levis M, D'AmicoM, Usmiani T, Fava A, Sbarra P, Burdese M, Segoloni GP, Colombo A, Marra S: Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J 161: 963-971, 2011
6. Solomon R: Contrast-induced acute kidney injury (CIAKI). Radiol Clin North Am 47: 783-788, v, 2009
7. Weisbord SD, Palevsky PM: Contrast-induced acute kidney injury: Short- and long-term implications. Semin Nephrol 31: 300-309, 2011
8. Rudnick M, Feldman H: Contrast-induced nephropathy: What are the true clinical consequences? Clin J Am Soc Nephrol 3: 263-272, 2008
9. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrastmedia-associated nephrotoxicity. Curr Opin Nephrol Hypertens 5: 127-133, 1996
10. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002
11. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G: Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat RevMol Cell Biol 11: 700-714, 2010
12. Zhao Y, Tao Z, Xu Z, Tao Z, Chen B, Wang L, Li C, Chen L, Jia Q, Jia E, Zhu T, Yang Z: Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo. Toxicol Lett 202: 253-260, 2011
13. Quintavalle C, Brenca M, De Micco F, Fiore D, Romano S, Romano MF, Apone F, Bianco A, Zabatta MA, Troncone G, Briguori C, Condorelli G: In vivo and in vitro assessment of pathways involved in contrast mediainduced renal cells apoptosis. Cell Death Dis 2: e155, 2011
14. Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G: Contrast agents and renal cell apoptosis. Eur Heart J 29: 2569-2576, 2008
15. Yokomaku Y, Sugimoto T, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Nitta N, Haneda M, Koya D, Uzu T, Kashiwagi A: Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 19: 321-328, 2008
16. Boatright KM, Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol 15: 725-731, 2003
17. Pop C, Salvesen GS: Human caspases: Activation, specificity, and regulation. J Biol Chem 284: 21777-21781, 2009
18. Kroemer G, Galluzzi L, Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007
19. Devalaraja-Narashimha K, Padanilam BJ: PARP-1 inhibits glycolysis in ischemic kidneys. J Am Soc Nephrol 20: 95-103, 2009
20. Linkermann A, De Zen F, Weinberg J, Kunzendorf U, Krautwald S: Programmed necrosis in acute kidney injury. Nephrol Dial Transplant 27: 3412-3419, 2012
21. Challa S, Chan FK: Going up in flames: Necrotic cell injury and inflammatory diseases. Cell Mol Life Sci 67: 3241-3253, 2010
22. Christofferson DE, Yuan J: Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22: 263-268, 2010
23. Declercq W, Vanden Berghe T, Vandenabeele P: RIP kinases at the crossroads of cell death and survival. Cell 138: 229-232, 2009
24. Linkermann A, Himmerkus N, Rölver L, Keyser KA, Steen P, Bräsen JH, Bleich M, Kunzendorf U, Krautwald S: Renal tubular Fas ligandmediates fratricide in cisplatin-induced acute kidney failure. Kidney Int 79: 169-178, 2011
25. Linkermann A, Bräsen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S: Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81: 751-761, 2012
26. Biton S, Ashkenazi A: NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-a feedforward signaling. Cell 145: 92-103, 2011
27. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J: Chemical inhibitor of nonapoptotic cell deathwith therapeutic potential for ischemic brain injury. Nat Chem Biol 1: 112-119, 2005
28. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J: Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4: 313-321, 2008
29. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES: RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471: 368-372, 2011
30. Billings FT 4th, Chen SW, Kim M, Park SW, Song JH, Wang S, Herman J, D'Agati V, Lee HT: alpha2-Adrenergic agonists protect against radiocontrastinduced nephropathy inmice. Am J Physiol Renal Physiol 295: F741-F748, 2008
31. Krautwald S, Ziegler E, Rölver L, Linkermann A, Keyser KA, Steen P, Wollert KC, Korf-Klingebiel M, Kunzendorf U: Effective blockage of both the extrinsic and intrinsic pathways of apoptosis in mice by TATcrmA. J Biol Chem 285: 19997-20005, 2010
32. Linkermann A, Bräsen JH, De Zen F, Weinlich R, Schwendener RA, Green DR, Kunzendorf U, Krautwald S: Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-a-induced shock. Mol Med 18: 577-586, 2012
33. Heinrich MC: Osmotic nephrosis and contrast media. Am J Kidney Dis 52: 629-630, author reply 629-630, 2008
34. Dickenmann M, Oettl T, Mihatsch MJ: Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. AmJ Kidney Dis 51: 491-503, 2008
35. Moreau JF, Droz D, Sabto J, Jungers P, Kleinknecht D, Hinglais N, Michel JR: Osmotic nephrosis induced by water-soluble triiodinated contrast media in man. A retrospective study of 47 cases. Radiology 115: 329-336, 1975
36. Lee HT, Jan M, Bae SC, Joo JD, Goubaeva FR, Yang J, Kim M: A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am J Physiol Renal Physiol 290: F1367-F1375, 2006
37. Devalaraja-Narashimha K, Diener AM, Padanilam BJ: Cyclophilin D gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 297: F749-F759, 2009
38. Sanz AB, Sanchez-Niño MD, Ortiz A: TWEAK, amultifunctional cytokine in kidney injury. Kidney Int 80: 708-718, 2011
39. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nuñez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G: Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19: 107-120, 2012
40. Moquin D, Chan FK: Themolecular regulation of programmed necrotic cell injury. Trends Biochem Sci 35: 434-441, 2010
41. Oberst A, Green DR: It cuts both ways: Reconciling the dual roles of caspase 8 in cell death and survival. Nat RevMol Cell Biol 12: 757-763, 2011
42. Dunn KW, Sandoval RM, Kelly KJ, Dagher PC, Tanner GA, Atkinson SJ, Bacallao RL, Molitoris BA: Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol Cell Physiol 283: C905-C916, 2002
43. Peti-Peterdi J, Burford JL, Hackl MJ: The first decade of using multiphotonmicroscopy for high-power kidney imaging. Am J Physiol Renal Physiol 302: F227-F233, 2012
44. Porter GA: Experimental contrast-associated nephropathy and its clinical implications. Am J Cardiol 66: 18F-22F, 1990
45. Sendeski MM, Persson AB, Liu ZZ, Busch JF, Weikert S, Persson PB, Hippenstiel S, Patzak A: Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta. Am J Physiol Renal Physiol 303: F1592-F1598, 2012
46. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, HajnóczkyG, Hardwick JM, Hengartner MO, Ichijo H, Jäättelä M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nuñez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G: Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16: 1093-1107, 2009
47. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G; Nomenclature Committee on Cell Death 2009: Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11, 2009
48. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, Isakson BE, Bayliss DA, Ravichandran KS: Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467: 863-867, 2010
49. McStay GP, Salvesen GS, Green DR: Overlapping cleavage motif selectivity of caspases: Implications for analysis of apoptotic pathways. Cell Death Differ 15: 322-331, 2008
50. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemiareperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009
51. Ko GJ, Jang HR, Huang Y, Womer KL, Liu M, Higbee E, Xiao Z, Yagita H, Racusen L, Hamad AR, Rabb H: Blocking Fas ligand onleukocytes attenuates kidney ischemia-reperfusion injury. J Am Soc Nephrol 22: 732-742, 2011
52. Li L, Huang L, Ye H, Song SP, Bajwa A, Lee SJ, Moser EK, Jaworska K, Kinsey GR, Day YJ, Linden J, Lobo PI, Rosin DL, Okusa MD: Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest 122: 3931-3942, 2012
53. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P: RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 14: 400-410, 2007
54. Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D: Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38: 27-40, 2013
55. Doi K, Leelahavanichkul A, Yuen PS, Star RA: Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119: 2868-2878, 2009
56. Ebcioglu Z, Cohen DJ, Crew RJ, Hardy MA, Ratner LE, D'Agati VD, Markowitz GS: Osmotic nephrosis in a renal transplant recipient. Kidney Int 70: 1873-1876, 2006
57. Venkatachalam MA, Weinberg JM: The tubule pathology of septic acute kidney injury: A neglected area of research comes of age. Kidney Int 81: 338-340, 2012
58. Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T, Declercq W, Libert C, Cauwels A, Vandenabeele P: RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35: 908-918, 2011
59. Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J: Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471: 373-376, 2011
60. Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G: Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 126: 3008-3016, 2012